MedPath

THE UNIVERSITY OF QUEENSLAND

THE UNIVERSITY OF QUEENSLAND logo
🇦🇺Australia
Ownership
Private
Established
1909-01-01
Employees
5K
Market Cap
-
Website
http://www.uq.edu.au

Clinical Trials

338

Active:19
Completed:121

Trial Phases

5 Phases

Phase 1:17
Phase 2:20
Phase 3:21
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (305 trials with phase data)• Click on a phase to view related trials

Not Applicable
229 (75.1%)
Phase 3
21 (6.9%)
Phase 2
20 (6.6%)
Phase 4
18 (5.9%)
Phase 1
17 (5.6%)

Perception of Health Promotion Messages

Not Applicable
Completed
Conditions
Perception of Vaping
First Posted Date
2025-06-29
Last Posted Date
2025-06-29
Lead Sponsor
The University of Queensland
Target Recruit Count
763
Registration Number
NCT07042789
Locations
🇦🇺

National Centre for Youth Substance Use Research, Brisbane, Queensland, Australia

Chlorhexidine Caps for CLABSI Prevention in Hemodialysis: a Pilot Randomized Controlled Trial

Not Applicable
Not yet recruiting
Conditions
Vascular Access Complication
Device Related Infection
Catheter Infection
Catheter Complications
Catheter-Related Infections
Catheter Related Complications
Hemodialysis Catheter Infection
Hemodialysis Catheter-associated Infection
Hemodialysis Complication
Device Related Sepsis
First Posted Date
2025-06-13
Last Posted Date
2025-06-13
Lead Sponsor
The University of Queensland
Target Recruit Count
60
Registration Number
NCT07019610
Locations
🇦🇺

Royal Brisbane and Women's Hospital, Herston, Queensland, Australia

Pasteurised Donor Human Milk Supplementation for Term Babies

Phase 4
Not yet recruiting
Conditions
Neonatal Hypoglycemia
Metabolic Complication
Cows Milk Allergy
Hospital Length of Stay
Neonatal Intensive Care Unit
Breastfeeding
Mental Health Issue
First Posted Date
2025-05-28
Last Posted Date
2025-05-28
Lead Sponsor
The University of Queensland
Target Recruit Count
1444
Registration Number
NCT06993103
Locations
🇦🇺

Royal Brisbane and Womens Hospital (QLD), Brisbane, Queensland, Australia

🇦🇺

Greenslope Hospital (QLD), Brisbane, Queensland, Australia

🇦🇺

Frances Perry House (VIC), Melbourne, Victoria, Australia

and more 1 locations

SPINEPASS: SPINE Self-management Techniques for Persistent Headache After Concussion: Physical Therapy Targeting Autonomic and Dura Mater Function.

Not Applicable
Not yet recruiting
Conditions
Persistent Post-concussive Symptoms
Post Traumatic Headache
First Posted Date
2025-03-18
Last Posted Date
2025-03-18
Lead Sponsor
The University of Queensland
Target Recruit Count
120
Registration Number
NCT06882239
Locations
🇺🇸

Brook Army Medical Center, San Antonio, Texas, United States

Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (The PIVO Trial)

Not Applicable
Not yet recruiting
Conditions
Blood Culture Contamination
Infection
First Posted Date
2025-02-04
Last Posted Date
2025-02-12
Lead Sponsor
The University of Queensland
Target Recruit Count
1148
Registration Number
NCT06806709
Locations
🇦🇺

Caboolture Hospital, Caboolture, Queensland, Australia

🇦🇺

Redcliffe Hospital, Redcliffe, Queensland, Australia

🇦🇺

The Gold Coast University Hospital, Southport, Queensland, Australia

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 17
  • Next

News

First Nanobody Treatment Shows Promise Against Deadly Nipah and Hendra Viruses

University of Queensland researchers have identified DS90, the first nanobody capable of neutralizing both Nipah and Hendra viruses, for which no approved vaccines or cures currently exist.

World-First Immunotherapy Trial Aims to Reprogram Immune System in Type 1 Diabetes

Australian researchers at The University of Queensland have dosed the first five participants in a groundbreaking clinical trial of ASITI-201, an immunotherapy designed to rebalance immune response in Type 1 diabetes.

Breakthrough Blood Test for Early Ovarian Cancer Detection Enters Clinical Trials in Australia

The University of Queensland is launching a clinical trial of a novel blood test that has shown 94% accuracy in detecting early-stage ovarian cancer, potentially revolutionizing screening for this deadly disease.

© Copyright 2025. All Rights Reserved by MedPath